United States Biotechnology & Medical Research

BioXcel Therapeutics Inc (BTAI)

Track

BioXcel Therapeutics Inc. experienced significant insider trading activity recently, characterized exclusively by planned and proposed sales. Key executives, including the CEO and CFO, divested shares totaling over $86,000. These disposals occurred amidst a period where the firm reported a substantial miss in its latest earnings report, despite a modest 5.3% stock price increase over ninety days.
Ticker: BTAI Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for BioXcel Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.3
Yocca Frank Chief Scientific Officer Officer
Transaction date
Planned sale
Price
12.19
Quantity 90,837 +19.0%
Value US$4,008,016
Rodriguez Javier See Remarks Officer
Transaction date
Planned sale
Price
11.27
Quantity 10,704 +38.9%
Value US$152,874
2.7
Steinhart Richard I Chief Financial Officer Officer
Transaction date
Planned sale
Price
361.44
Quantity 68,576 -4.2%
Value US$1,934,612
3.3
Mehta Vimal CEO and President Executive Director
Transaction date
Planned sale
Price
1.09
Quantity 19,419 -21.8%
Value US$21,108
Rodriguez Javier Officer Officer
Transaction date
Proposed sale
Price
1.08
Quantity 6,560
Value US$7,109
3.3
Mehta Vimal Officer Officer
Transaction date
Proposed sale
Price
1.09
Quantity 19,419
Value US$21,114
2.3
Yocca Frank Officer Officer
Transaction date
Proposed sale
Price
1.09
Quantity 6,845
Value US$7,430
2.7
Steinhart Richard I Officer Officer
Transaction date
Proposed sale
Price
1.08
Quantity 6,845
Value US$7,426
O'Neill Vincent See Remarks Officer
Transaction date
Planned sale
Price
0.35
Quantity 165 -0.8%
Value US$58
2.3
Yocca Frank Chief Scientific Officer Officer
Transaction date
Planned sale
Price
0.35
Quantity 225 -0.8%
Value US$79
2.3
Yocca Frank Chief Scientific Officer Officer
Transaction date
Planned sale
Price
0.36
Quantity 205 -0.7%
Value US$73
3.3
Mehta Vimal CEO and President Executive Director Large shareholder
Transaction date
Planned sale
Price
0.36
Quantity 2,134 -3.5%
Value US$773
3.3
Mehta Vimal CEO and President Executive Director Large shareholder
Transaction date
Planned sale
Price
0.36
Quantity 983 -1.6%
Value US$358
Rodriguez Javier See Remarks Officer
Transaction date
Planned sale
Price
0.36
Quantity 220 -0.9%
Value US$78
Rodriguez Javier See Remarks Officer
Transaction date
Planned sale
Price
0.36
Quantity 210 -0.8%
Value US$75
2.7
Steinhart Richard I Chief Financial Officer Officer
Transaction date
Planned sale
Price
0.36
Quantity 372 -1.7%
Value US$133
2.7
Steinhart Richard I Chief Financial Officer Officer
Transaction date
Planned sale
Price
0.36
Quantity 205 -1.0%
Value US$74
O'Neill Vincent Officer Officer
Transaction date
Proposed sale
Price
0.35
Quantity 165
Value US$58
Rodriguez Javier Officer Officer
Transaction date
Proposed sale
Price
0.36
Quantity 430
Value US$153
2.7
Steinhart Richard I Officer Officer
Transaction date
Proposed sale
Price
0.36
Quantity 430
Value US$154
2.3
Yocca Frank Officer Officer
Transaction date
Proposed sale
Price
0.35
Quantity 430
Value US$152
2.7
Steinhart Richard I Officer Officer
Transaction date
Proposed sale
Price
0.35
Quantity 438
Value US$154
3.3
Mehta Vimal Officer Officer
Transaction date
Proposed sale
Price
0.34
Quantity 1,315
Value US$453
3.3
Mehta Vimal Officer Officer
Transaction date
Proposed sale
Price
0.35
Quantity 983
Value US$340
Rodriguez Javier Officer Officer
Transaction date
Proposed sale
Price
0.55
Quantity 6,863
Value US$3,776
Wiley Matthew T. Officer Officer
Transaction date
Proposed sale
Price
0.55
Quantity 6,272
Value US$3,450
O'Neill Vincent Officer Officer
Transaction date
Proposed sale
Price
0.55
Quantity 5,556
Value US$3,056
2.3
Yocca Frank Officer Officer
Transaction date
Proposed sale
Price
0.55
Quantity 7,175
Value US$3,946
2.7
Steinhart Richard I Officer Officer
Transaction date
Proposed sale
Price
0.55
Quantity 7,175
Value US$3,947
O'Neill Vincent See Remarks Officer
Transaction date
Planned sale
Price
0.55
Quantity 5,556 -22.1%
Value US$3,056
2.3
Yocca Frank Chief Scientific Officer Officer
Transaction date
Planned sale
Price
0.55
Quantity 7,175 -20.2%
Value US$3,946
Rodriguez Javier See Remarks Officer
Transaction date
Planned sale
Price
0.55
Quantity 6,863 -22.4%
Value US$3,775
2.7
Steinhart Richard I Chief Financial Officer Officer
Transaction date
Planned sale
Price
0.55
Quantity 7,175 -26.1%
Value US$3,946
Wiley Matthew T. Chief Commercial Officer Officer
Transaction date
Planned sale
Price
0.55
Quantity 6,272 -24.8%
Value US$3,450
3.3
Mehta Vimal CEO and President Executive Director Large shareholder
Transaction date
Planned sale
Price
0.69
Quantity 1,150 -2.2%
Value US$794
3.3
Mehta Vimal CEO and President Executive Director Large shareholder
Transaction date
Planned sale
Price
0.69
Quantity 832 -1.6%
Value US$573
2.7
Steinhart Richard I Chief Financial Officer Officer
Transaction date
Planned sale
Price
0.69
Quantity 356 -5.4%
Value US$246
Rodriguez Javier See Remarks Officer
Transaction date
Planned sale
Price
0.69
Quantity 345 -3.6%
Value US$238
Wiley Matthew T. Chief Commercial Officer Officer
Transaction date
Planned sale
Price
0.69
Quantity 215 -5.1%
Value US$149
O'Neill Vincent See Remarks Officer
Transaction date
Planned sale
Price
0.69
Quantity 138 -3.4%
Value US$95
2.3
Yocca Frank Chief Scientific Officer Officer
Transaction date
Planned sale
Price
0.69
Quantity 355 -2.4%
Value US$245
2.3
Yocca Frank Officer Officer
Transaction date
Proposed sale
Price
0.69
Quantity 355
Value US$245
Wiley Matthew T. Officer Officer
Transaction date
Proposed sale
Price
0.69
Quantity 215
Value US$149
Rodriguez Javier Officer Officer
Transaction date
Proposed sale
Price
0.69
Quantity 345
Value US$238
O'Neill Vincent Officer Officer
Transaction date
Proposed sale
Price
0.69
Quantity 138
Value US$95
2.7
Steinhart Richard I Officer Officer
Transaction date
Proposed sale
Price
0.69
Quantity 356
Value US$246
3.3
Mehta Vimal Officer Officer
Transaction date
Proposed sale
Price
0.69
Quantity 1,150
Value US$794
3.3
Mehta Vimal Officer Officer
Transaction date
Proposed sale
Price
0.69
Quantity 832
Value US$574
2.3
Yocca Frank Chief Scientific Officer Officer
Transaction date
Planned sale
Price
1.28
Quantity 372 -2.7%
Value US$476
Rodriguez Javier See Remarks Officer
Transaction date
Planned sale
Price
1.26
Quantity 361 -4.1%
Value US$456
2.7
Steinhart Richard I Chief Financial Officer Officer
Transaction date
Planned sale
Price
1.26
Quantity 372 -6.4%
Value US$470
3.3
Mehta Vimal CEO and President Executive Director Large shareholder
Transaction date
Planned sale
Price
1.28
Quantity 2,134 -4.3%
Value US$2,739
Wiley Matthew T. Chief Commercial Officer Officer
Transaction date
Planned sale
Price
1.26
Quantity 244 -6.5%
Value US$308
O'Neill Vincent See Remarks Officer
Transaction date
Planned sale
Price
1.29
Quantity 155 -4.2%
Value US$199
Rodriguez Javier Officer Officer
Transaction date
Proposed sale
Price
1.26
Quantity 361
Value US$456
Wiley Matthew T. Officer Officer
Transaction date
Proposed sale
Price
1.26
Quantity 244
Value US$308
O'Neill Vincent Officer Officer
Transaction date
Proposed sale
Price
1.29
Quantity 155
Value US$199
2.3
Yocca Frank Officer Officer
Transaction date
Proposed sale
Price
1.28
Quantity 372
Value US$476
2.7
Steinhart Richard I Officer Officer
Transaction date
Proposed sale
Price
1.26
Quantity 372
Value US$470
3.3
Mehta Vimal Officer Officer
Transaction date
Proposed sale
Price
1.29
Quantity 909
Value US$1,173
3.3
Mehta Vimal Officer Officer
Transaction date
Proposed sale
Price
1.17
Quantity 1,225
Value US$1,429
3.3
Mehta Vimal CEO and President Executive Director Large shareholder
Transaction date
Sale
Price
1.58
Quantity 126,014 -1.6%
Value US$199,619
3.3
Mehta Vimal CEO and President Executive Director Large shareholder
Transaction date
Sale
Price
1.63
Quantity 126,014 -1.6%
Value US$205,516
2.3
BioXcel LLC 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
1.50
Quantity 252,028
Value US$378,042
Rodriguez Javier See Remarks Officer
Transaction date
Planned sale
Price
2.64
Quantity 1,012 -11.7%
Value US$2,667
2.7
Steinhart Richard I Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.64
Quantity 1,069 -18.3%
Value US$2,817
O'Neill Vincent See Remarks Officer
Transaction date
Planned sale
Price
2.62
Quantity 165 -3.0%
Value US$432
3.3
Mehta Vimal CEO and President Executive Director
Transaction date
Planned sale
Price
2.62
Quantity 4,439 -9.2%
Value US$11,651
3.3
Mehta Vimal CEO and President Executive Director
Transaction date
Planned sale
Price
2.62
Quantity 829 -1.7%
Value US$2,172
2.3
Yocca Frank Chief Scientific Officer Officer
Transaction date
Planned sale
Price
2.64
Quantity 1,067 -7.7%
Value US$2,812
Wiley Matthew T. CHIEF COMMERCIAL OFFICER Officer
Transaction date
Planned sale
Price
2.64
Quantity 1,008 -25.2%
Value US$2,656
2.7
Steinhart Richard I Officer Officer
Transaction date
Proposed sale
Price
2.63
Quantity 1,069
Value US$2,810
Rodriguez Javier Officer Officer
Transaction date
Proposed sale
Price
2.63
Quantity 1,012
Value US$2,662
Wiley Matthew T. Officer Officer
Transaction date
Proposed sale
Price
2.63
Quantity 1,008
Value US$2,651
3.3
Mehta Vimal Officer Officer
Transaction date
Proposed sale
Price
2.62
Quantity 4,439
Value US$11,651
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-22 2026-05-20 PlS Planned sale
2.3
Yocca Frank

Chief Scientific Officer

Officer
90,837 +19.0%
12.19
US$4,008,016 		90,837 +19.0% 12.19 US$4,008,016
2026-05-22 2026-05-20 PlS Planned sale
Rodriguez Javier

See Remarks

Officer
10,704 +38.9%
11.27
US$152,874 		10,704 +38.9% 11.27 US$152,874
2026-05-22 2026-05-20 PlS Planned sale
2.7
Steinhart Richard I

Chief Financial Officer

Officer
68,576 -4.2%
361.44
US$1,934,612 		68,576 -4.2% 361.44 US$1,934,612
2026-05-22 2026-05-20 PlS Planned sale
3.3
Mehta Vimal

CEO and President

Executive Director
19,419 -21.8%
1.09
US$21,108 		19,419 -21.8% 1.09 US$21,108
2026-05-20 2026-05-20 PrS Proposed sale
Rodriguez Javier

Officer

Officer
6,560
1.08
US$7,109 		6,560 1.08 US$7,109
2026-05-20 2026-05-20 PrS Proposed sale
3.3
Mehta Vimal

Officer

Officer
19,419
1.09
US$21,114 		19,419 1.09 US$21,114
2026-05-20 2026-05-20 PrS Proposed sale
2.3
Yocca Frank

Officer

Officer
6,845
1.09
US$7,430 		6,845 1.09 US$7,430
2026-05-20 2026-05-20 PrS Proposed sale
2.7
Steinhart Richard I

Officer

Officer
6,845
1.08
US$7,426 		6,845 1.08 US$7,426
2024-12-17 2024-12-16 PlS Planned sale
O'Neill Vincent

See Remarks

Officer
165 -0.8%
0.35
US$58 		165 -0.8% 0.35 US$58
2024-12-17 2024-12-16 PlS Planned sale
2.3
Yocca Frank

Chief Scientific Officer

Officer
225 -0.8%
0.35
US$79 		225 -0.8% 0.35 US$79
2024-12-17 2024-12-16 PlS Planned sale
2.3
Yocca Frank

Chief Scientific Officer

Officer
205 -0.7%
0.36
US$73 		205 -0.7% 0.36 US$73
2024-12-17 2024-12-16 PlS Planned sale
3.3
Mehta Vimal

CEO and President

Executive Director Large shareholder
2,134 -3.5%
0.36
US$773 		2,134 -3.5% 0.36 US$773
2024-12-17 2024-12-16 PlS Planned sale
3.3
Mehta Vimal

CEO and President

Executive Director Large shareholder
983 -1.6%
0.36
US$358 		983 -1.6% 0.36 US$358
2024-12-17 2024-12-16 PlS Planned sale
Rodriguez Javier

See Remarks

Officer
220 -0.9%
0.36
US$78 		220 -0.9% 0.36 US$78
2024-12-17 2024-12-16 PlS Planned sale
Rodriguez Javier

See Remarks

Officer
210 -0.8%
0.36
US$75 		210 -0.8% 0.36 US$75
2024-12-17 2024-12-16 PlS Planned sale
2.7
Steinhart Richard I

Chief Financial Officer

Officer
372 -1.7%
0.36
US$133 		372 -1.7% 0.36 US$133
2024-12-17 2024-12-16 PlS Planned sale
2.7
Steinhart Richard I

Chief Financial Officer

Officer
205 -1.0%
0.36
US$74 		205 -1.0% 0.36 US$74
2024-12-16 2024-12-16 PrS Proposed sale
O'Neill Vincent

Officer

Officer
165
0.35
US$58 		165 0.35 US$58
2024-12-16 2024-12-16 PrS Proposed sale
Rodriguez Javier

Officer

Officer
430
0.36
US$153 		430 0.36 US$153
2024-12-16 2024-12-16 PrS Proposed sale
2.7
Steinhart Richard I

Officer

Officer
430
0.36
US$154 		430 0.36 US$154
2024-12-16 2024-12-16 PrS Proposed sale
2.3
Yocca Frank

Officer

Officer
430
0.35
US$152 		430 0.35 US$152
2024-12-16 2024-12-16 PrS Proposed sale
2.7
Steinhart Richard I

Officer

Officer
438
0.35
US$154 		438 0.35 US$154
2024-12-16 2024-12-16 PrS Proposed sale
3.3
Mehta Vimal

Officer

Officer
1,315
0.34
US$453 		1,315 0.34 US$453
2024-12-16 2024-12-16 PrS Proposed sale
3.3
Mehta Vimal

Officer

Officer
983
0.35
US$340 		983 0.35 US$340
2024-10-03 2024-10-03 PrS Proposed sale
Rodriguez Javier

Officer

Officer
6,863
0.55
US$3,776 		6,863 0.55 US$3,776
2024-10-03 2024-10-03 PrS Proposed sale
Wiley Matthew T.

Officer

Officer
6,272
0.55
US$3,450 		6,272 0.55 US$3,450
2024-10-03 2024-10-03 PrS Proposed sale
O'Neill Vincent

Officer

Officer
5,556
0.55
US$3,056 		5,556 0.55 US$3,056
2024-10-03 2024-10-03 PrS Proposed sale
2.3
Yocca Frank

Officer

Officer
7,175
0.55
US$3,946 		7,175 0.55 US$3,946
2024-10-03 2024-10-03 PrS Proposed sale
2.7
Steinhart Richard I

Officer

Officer
7,175
0.55
US$3,947 		7,175 0.55 US$3,947
2024-10-03 2024-10-03 PlS Planned sale
O'Neill Vincent

See Remarks

Officer
5,556 -22.1%
0.55
US$3,056 		5,556 -22.1% 0.55 US$3,056
2024-10-03 2024-10-03 PlS Planned sale
2.3
Yocca Frank

Chief Scientific Officer

Officer
7,175 -20.2%
0.55
US$3,946 		7,175 -20.2% 0.55 US$3,946
2024-10-03 2024-10-03 PlS Planned sale
Rodriguez Javier

See Remarks

Officer
6,863 -22.4%
0.55
US$3,775 		6,863 -22.4% 0.55 US$3,775
2024-10-03 2024-10-03 PlS Planned sale
2.7
Steinhart Richard I

Chief Financial Officer

Officer
7,175 -26.1%
0.55
US$3,946 		7,175 -26.1% 0.55 US$3,946
2024-10-03 2024-10-03 PlS Planned sale
Wiley Matthew T.

Chief Commercial Officer

Officer
6,272 -24.8%
0.55
US$3,450 		6,272 -24.8% 0.55 US$3,450
2024-09-17 2024-09-16 PlS Planned sale
3.3
Mehta Vimal

CEO and President

Executive Director Large shareholder
1,150 -2.2%
0.69
US$794 		1,150 -2.2% 0.69 US$794
2024-09-17 2024-09-16 PlS Planned sale
3.3
Mehta Vimal

CEO and President

Executive Director Large shareholder
832 -1.6%
0.69
US$573 		832 -1.6% 0.69 US$573
2024-09-17 2024-09-16 PlS Planned sale
2.7
Steinhart Richard I

Chief Financial Officer

Officer
356 -5.4%
0.69
US$246 		356 -5.4% 0.69 US$246
2024-09-17 2024-09-16 PlS Planned sale
Rodriguez Javier

See Remarks

Officer
345 -3.6%
0.69
US$238 		345 -3.6% 0.69 US$238
2024-09-17 2024-09-16 PlS Planned sale
Wiley Matthew T.

Chief Commercial Officer

Officer
215 -5.1%
0.69
US$149 		215 -5.1% 0.69 US$149
2024-09-17 2024-09-16 PlS Planned sale
O'Neill Vincent

See Remarks

Officer
138 -3.4%
0.69
US$95 		138 -3.4% 0.69 US$95
2024-09-17 2024-09-16 PlS Planned sale
2.3
Yocca Frank

Chief Scientific Officer

Officer
355 -2.4%
0.69
US$245 		355 -2.4% 0.69 US$245
2024-09-16 2024-09-16 PrS Proposed sale
2.3
Yocca Frank

Officer

Officer
355
0.69
US$245 		355 0.69 US$245
2024-09-16 2024-09-16 PrS Proposed sale
Wiley Matthew T.

Officer

Officer
215
0.69
US$149 		215 0.69 US$149
2024-09-16 2024-09-16 PrS Proposed sale
Rodriguez Javier

Officer

Officer
345
0.69
US$238 		345 0.69 US$238
2024-09-16 2024-09-16 PrS Proposed sale
O'Neill Vincent

Officer

Officer
138
0.69
US$95 		138 0.69 US$95
2024-09-16 2024-09-16 PrS Proposed sale
2.7
Steinhart Richard I

Officer

Officer
356
0.69
US$246 		356 0.69 US$246
2024-09-16 2024-09-16 PrS Proposed sale
3.3
Mehta Vimal

Officer

Officer
1,150
0.69
US$794 		1,150 0.69 US$794
2024-09-16 2024-09-16 PrS Proposed sale
3.3
Mehta Vimal

Officer

Officer
832
0.69
US$574 		832 0.69 US$574
2024-06-18 2024-06-17 PlS Planned sale
2.3
Yocca Frank

Chief Scientific Officer

Officer
372 -2.7%
1.28
US$476 		372 -2.7% 1.28 US$476
2024-06-18 2024-06-17 PlS Planned sale
Rodriguez Javier

See Remarks

Officer
361 -4.1%
1.26
US$456 		361 -4.1% 1.26 US$456
2024-06-18 2024-06-17 PlS Planned sale
2.7
Steinhart Richard I

Chief Financial Officer

Officer
372 -6.4%
1.26
US$470 		372 -6.4% 1.26 US$470
2024-06-18 2024-06-17 PlS Planned sale
3.3
Mehta Vimal

CEO and President

Executive Director Large shareholder
2,134 -4.3%
1.28
US$2,739 		2,134 -4.3% 1.28 US$2,739
2024-06-18 2024-06-17 PlS Planned sale
Wiley Matthew T.

Chief Commercial Officer

Officer
244 -6.5%
1.26
US$308 		244 -6.5% 1.26 US$308
2024-06-18 2024-06-17 PlS Planned sale
O'Neill Vincent

See Remarks

Officer
155 -4.2%
1.29
US$199 		155 -4.2% 1.29 US$199
2024-06-17 2024-06-17 PrS Proposed sale
Rodriguez Javier

Officer

Officer
361
1.26
US$456 		361 1.26 US$456
2024-06-17 2024-06-17 PrS Proposed sale
Wiley Matthew T.

Officer

Officer
244
1.26
US$308 		244 1.26 US$308
2024-06-17 2024-06-17 PrS Proposed sale
O'Neill Vincent

Officer

Officer
155
1.29
US$199 		155 1.29 US$199
2024-06-17 2024-06-17 PrS Proposed sale
2.3
Yocca Frank

Officer

Officer
372
1.28
US$476 		372 1.28 US$476
2024-06-17 2024-06-17 PrS Proposed sale
2.7
Steinhart Richard I

Officer

Officer
372
1.26
US$470 		372 1.26 US$470
2024-06-17 2024-06-17 PrS Proposed sale
3.3
Mehta Vimal

Officer

Officer
909
1.29
US$1,173 		909 1.29 US$1,173
2024-06-17 2024-06-17 PrS Proposed sale
3.3
Mehta Vimal

Officer

Officer
1,225
1.17
US$1,429 		1,225 1.17 US$1,429
2024-06-06 2024-06-05 S Sale
3.3
Mehta Vimal

CEO and President

Executive Director Large shareholder
126,014 -1.6%
1.58
US$199,619 		126,014 -1.6% 1.58 US$199,619
2024-06-06 2024-06-04 S Sale
3.3
Mehta Vimal

CEO and President

Executive Director Large shareholder
126,014 -1.6%
1.63
US$205,516 		126,014 -1.6% 1.63 US$205,516
2024-06-04 2024-06-04 PrS Proposed sale
2.3
BioXcel LLC

10% Stockholder

Large shareholder
252,028
1.50
US$378,042 		252,028 1.50 US$378,042
2024-04-08 2024-04-04 PlS Planned sale
Rodriguez Javier

See Remarks

Officer
1,012 -11.7%
2.64
US$2,667 		1,012 -11.7% 2.64 US$2,667
2024-04-08 2024-04-04 PlS Planned sale
2.7
Steinhart Richard I

Chief Financial Officer

Officer
1,069 -18.3%
2.64
US$2,817 		1,069 -18.3% 2.64 US$2,817
2024-04-08 2024-04-04 PlS Planned sale
O'Neill Vincent

See Remarks

Officer
165 -3.0%
2.62
US$432 		165 -3.0% 2.62 US$432
2024-04-08 2024-04-04 PlS Planned sale
3.3
Mehta Vimal

CEO and President

Executive Director
4,439 -9.2%
2.62
US$11,651 		4,439 -9.2% 2.62 US$11,651
2024-04-08 2024-04-04 PlS Planned sale
3.3
Mehta Vimal

CEO and President

Executive Director
829 -1.7%
2.62
US$2,172 		829 -1.7% 2.62 US$2,172
2024-04-08 2024-04-04 PlS Planned sale
2.3
Yocca Frank

Chief Scientific Officer

Officer
1,067 -7.7%
2.64
US$2,812 		1,067 -7.7% 2.64 US$2,812
2024-04-08 2024-04-04 PlS Planned sale
Wiley Matthew T.

CHIEF COMMERCIAL OFFICER

Officer
1,008 -25.2%
2.64
US$2,656 		1,008 -25.2% 2.64 US$2,656
2024-04-04 2024-04-04 PrS Proposed sale
2.7
Steinhart Richard I

Officer

Officer
1,069
2.63
US$2,810 		1,069 2.63 US$2,810
2024-04-04 2024-04-04 PrS Proposed sale
Rodriguez Javier

Officer

Officer
1,012
2.63
US$2,662 		1,012 2.63 US$2,662
2024-04-04 2024-04-04 PrS Proposed sale
Wiley Matthew T.

Officer

Officer
1,008
2.63
US$2,651 		1,008 2.63 US$2,651
2024-04-04 2024-04-04 PrS Proposed sale
3.3
Mehta Vimal

Officer

Officer
4,439
2.62
US$11,651 		4,439 2.62 US$11,651
Explore more

More insider trading research around BioXcel Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America